NCT01384513 2026-04-15A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesThomas Jefferson UniversityPhase 2 Completed40 enrolled 15 charts
NCT04541017 2025-10-16Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to TreatmentNational Cancer Institute (NCI)Phase 1/2 Terminated8 enrolled 8 charts
NCT03695471 2025-08-29Pembrolizumab in Treating Patients With Stage IB-IV Mycosis FungoidesMayo ClinicPhase 2 Completed9 enrolled 15 charts
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts